Solicitation of Nominations for Appointment to the Interagency Committee on Smoking and Health (ICSH), 53316-53317 [2021-20920]
Download as PDF
<![CDATA[
53316
Federal Register / Vol. 86, No. 184 / Monday, September 27, 2021 / Notices
modules (risk factors/conditions/
demographics) that assess how
evidence-based health promotion
strategies are implemented at a
worksite. These strategies include
health promoting counseling services,
environmental supports, policies, health
plan benefits, and other worksite
programs shown to be effective in
preventing disease and promoting
healthy lifestyles for employees.
Employers can use this tool to assess
how a comprehensive health promotion
and disease prevention program is
offered to their employees, to help
identify program gaps, and to prioritize
high-impact health promotion strategies
to be incorporated into their programs.
This is an Extension Information
Collection Request (ICR) enabling
existing users, as well as new users to
continue to have access to the CDC
ScoreCard, a web-based organizational
assessment tool designed to help
employers identify gaps in their health
promotion programs and prioritize highimpact strategies for health promotion at
their worksites (available at https://
www.cdc.gov/healthscorecard).
CDC ScoreCard users will create a
user account, complete the online
assessment, and receive an immediate
feedback report that summarizes the
current status of their worksite health
program; identifies gaps in current
programming; benchmarks individual
employer results against other users of
the system; and provides access to
worksite health tools and resources to
address employer gaps and priority
program areas. To realize the full benefit
of the tool, employers are encouraged to
reassess their progress on an annual
basis and track improvements over time.
CDC will continue to provide outreach
to and to register approximately 800
employers per year to use the online
survey CDC ScoreCard in their
workplace health program assessment,
planning, and implementation efforts.
CDC Scorecard is open to employers of
all sizes, industry sectors, and
geographic locations across the country.
CDC will continue to use the
information gathered from the Scorecard
to provide better technical assistance,
training, and support to employers
seeking guidance on building or
maintaining workplace health
promotion programs including tool and
resource development for program
planning, implementation, and
evaluation related to the CDC
ScoreCard’s strategies.
OMB approval is requested for three
years. CDC requests approval for an
estimated 1,000 burden hours annually.
Participation is voluntary and there are
no costs to respondents other than their
time.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hrs)
Total burden
(in hrs)
Form name
Employers .........................................
CDC Worksite Health Scorecard .....
800
1
75/60
1,000
Total ...........................................
...........................................................
........................
........................
........................
1,000
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–20847 Filed 9–24–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Interagency
Committee on Smoking and Health
(ICSH)
ACTION:
Notice.
The Centers for Disease
Control and Prevention (CDC) is seeking
nominations for membership on the
ICSH. The ICSH consists of five public
members, as deemed by statute, that
represent private entities involved in
informing the public about the health
effects of smoking.
DATES: Nominations for membership on
the ICSH must be received no later than
October 22, 2021. Packages received
after this time will not be considered for
the current membership cycle.
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Number of
responses
per
respondent
Number of
respondents
Type of respondent
VerDate Sep<11>2014
18:08 Sep 24, 2021
Jkt 253001
All nominations should be
emailed to Jade Chambers Blair, Office
on Smoking and Health, National Center
for Chronic Disease Prevention and
Health Promotion (NCCDPHP), CDC, to
JChambersBlair@cdc.gov.
FOR FURTHER INFORMATION CONTACT:
Kathy Gallagher, Designated Federal
Official, ICSH, Office on Smoking and
Health, NCCDPHP, CDC, 1600 Clifton
Road NE, Atlanta, Georgia 30329–4027,
Telephone: (404) 639–6358, or email at
KGallagher@cdc.gov.
SUPPLEMENTARY INFORMATION:
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishments of the committee’s
objectives. Nominees will be selected
based on expertise in the fields of the
health effects of smoking. Additionally,
desirable qualifications include: (1)
Knowledge of evidence based and
emerging commercial tobacco control
policies as well as experience in
analyzing, evaluating, and interpreting
Federal, State and/or local health or
regulatory policy; and/or (2) familiarity
and expertise in developing or
contributing to the development of
policies and/or programs to advance
health equity by identifying and
ADDRESSES:
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
eliminating commercial tobacco product
related inequities and disparities; (3)
knowledge of the intersection of
behavioral health conditions (mental
health and/or substance use disorders)
and commercial tobacco use/tobacco
control and/or (4) familiarity and
expertise with the treatment of
commercial tobacco use and
dependence, particularly with respect to
developing or contributing to
interventions for reducing tobaccorelated disparities and inequities in the
United States. Federal employees will
not be considered for membership.
Members may be invited to serve for
four-year terms.
Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of ICSH
objectives https://www.cdc.gov/tobacco/
about/icsh/index.htm.
The U.S. Department of Health and
Human Services policy stipulates that
committee membership be balanced in
terms of points of view represented, and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens,
E:\FR\FM\27SEN1.SGM
27SEN1
Federal Register / Vol. 86, No. 184 / Monday, September 27, 2021 / Notices
lotter on DSK11XQN23PROD with NOTICES1
and cannot be full-time employees of
the U.S. Government. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees, requiring the filing of
financial disclosure reports at the
beginning and annually during their
terms. CDC reviews potential candidates
for ICSH membership each year and
provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment near
the start of the term in July 2022, or as
soon as the HHS selection process is
completed. Note that the need for
different expertise varies from year to
year and a candidate who is not selected
in one year may be reconsidered in a
subsequent year.
Candidates should submit the
following items:
D Current curriculum vitae, including
complete contact information
(telephone numbers, mailing address,
email address).
D At least one letter of
recommendation from person(s) not
employed by the U.S. Department of
Health and Human Services.
(Candidates may submit letter(s) from
current HHS employees if they wish,
but at least one letter must be submitted
by a person not employed by an HHS
agency (e.g., CDC, NIH, FDA, etc.).
Nominations may be submitted by the
candidate him- or herself, or by the
person/organization recommending the
candidate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–20920 Filed 9–24–21; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
18:08 Sep 24, 2021
Jkt 253001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3412–FN]
Medicare Program; Application by the
American Diabetes Association (ADA)
for Continued CMS Approval of Its
Diabetes Outpatient Self-Management
Training Program
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Final notice.
AGENCY:
This final notice announces
our decision to approve the American
Diabetes Association (ADA) application
for continued recognition as a national
accrediting organization (AO) for
accrediting entities that wish to furnish
diabetes outpatient self-management
training services to Medicare
beneficiaries.
SUMMARY:
This final notice is effective on
September 27, 2021 through September
27, 2027.
FOR FURTHER INFORMATION CONTACT:
Shannon Freeland, (410) 786–4348.
Caroline Gallaher, (410) 786–8705.
Lillian Williams, (410) 786–8636.
SUPPLEMENTARY INFORMATION:
DATES:
I. Background
Diabetes outpatient self-management
training services are defined at section
1861(qq)(1) of the Social Security Act
(the Act) as ‘‘educational and training
services furnished (at such times as the
Secretary determines appropriate) to an
individual with diabetes by a certified
provider (as described in paragraph
(2)(A)) in an outpatient setting by an
individual or entity who meets the
quality standards described in
paragraph (2)(B), but only if the
physician who is managing the
individual’s diabetic condition certifies
that such services are needed under a
comprehensive plan of care related to
the individual’s diabetic condition to
ensure therapy compliance or to provide
the individual with necessary skills and
knowledge (including skills related to
the self-administration of injectable
drugs) to participate in the management
of the individual’s condition.’’
In addition, section 1861(qq)(2)(A) of
the Act describes a ‘‘certified provider’’
as a physician, or other individual or
entity designated by the Secretary of the
Department of Health and Human
Services (the Secretary), that, in
addition to providing diabetes
outpatient self-management training
services, provides other items or
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
53317
services for which payment may be
made under this title. Section
1861(qq)(2)(B) of the Act further
specifies that a physician, or such other
individual or entity, must meet the
quality standards established by the
Secretary, except that the physician or
other individual or entity shall be
deemed to have met such standards if
the physician or other individual or
entity meets applicable standards
originally established by the National
Diabetes Advisory Board and
subsequently revised by organizations
who participated in the establishment of
standards by such Board or is
recognized by an organization that
represents individuals (including
individuals under this title) with
diabetes as meeting standards for
furnishing the services.
Section 1865 of the Act also permits
the Secretary to use accrediting bodies
to determine whether a provider entity
meets Medicare regulatory quality
standards, such as those established for
diabetes outpatient self-management
training programs. These accrediting
bodies determine whether a diabetes
outpatient self-management training
supplier meets the Medicare regulatory
quality standards established for
diabetes outpatient self-management
training service programs. A national
accrediting organization (AO) must be
approved by the Centers for Medicare &
Medicaid Services (CMS) and meet the
standards and requirements specified in
42 CFR part 410, subpart H, to qualify
for Medicare deeming authority.
Our regulations regarding the
application procedures for diabetes
outpatient self-management training
AOs seeking CMS approval are set forth
at 42 CFR 410.142. A national
accreditation organization applying for
deeming authority must provide CMS
with reasonable assurance that it will
require the diabetes outpatient selfmanagement training suppliers it
accredits to meet the CMS quality
standards, the National Standards for
Diabetes Self-Management Education
and Support (NSDSMES) standards, or
an alternative set of standards that meet
or exceed our requirements that have
been developed by that AO and that
have been approved by CMS (see 42
CFR 410.144) .
Section 410.142(a) of our regulations
states that ‘‘CMS may approve and
recognize a nonprofit organization with
demonstrated experience in
representing the interests of individuals
with diabetes to accredit entities to
furnish training.’’ Therefore, all diabetes
outpatient self-management training
AOs must be not-for-profit
organizations.
E:\FR\FM\27SEN1.SGM
27SEN1
]]>Agencies
[Federal Register Volume 86, Number 184 (Monday, September 27, 2021)]
[Notices]
[Pages 53316-53317]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20920]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Interagency
Committee on Smoking and Health (ICSH)
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) is
seeking nominations for membership on the ICSH. The ICSH consists of
five public members, as deemed by statute, that represent private
entities involved in informing the public about the health effects of
smoking.
DATES: Nominations for membership on the ICSH must be received no later
than October 22, 2021. Packages received after this time will not be
considered for the current membership cycle.
ADDRESSES: All nominations should be emailed to Jade Chambers Blair,
Office on Smoking and Health, National Center for Chronic Disease
Prevention and Health Promotion (NCCDPHP), CDC, to
[email protected].
FOR FURTHER INFORMATION CONTACT: Kathy Gallagher, Designated Federal
Official, ICSH, Office on Smoking and Health, NCCDPHP, CDC, 1600
Clifton Road NE, Atlanta, Georgia 30329-4027, Telephone: (404) 639-
6358, or email at [email protected].
SUPPLEMENTARY INFORMATION: Nominations are being sought for individuals
who have expertise and qualifications necessary to contribute to the
accomplishments of the committee's objectives. Nominees will be
selected based on expertise in the fields of the health effects of
smoking. Additionally, desirable qualifications include: (1) Knowledge
of evidence based and emerging commercial tobacco control policies as
well as experience in analyzing, evaluating, and interpreting Federal,
State and/or local health or regulatory policy; and/or (2) familiarity
and expertise in developing or contributing to the development of
policies and/or programs to advance health equity by identifying and
eliminating commercial tobacco product related inequities and
disparities; (3) knowledge of the intersection of behavioral health
conditions (mental health and/or substance use disorders) and
commercial tobacco use/tobacco control and/or (4) familiarity and
expertise with the treatment of commercial tobacco use and dependence,
particularly with respect to developing or contributing to
interventions for reducing tobacco-related disparities and inequities
in the United States. Federal employees will not be considered for
membership. Members may be invited to serve for four-year terms.
Selection of members is based on candidates' qualifications to
contribute to the accomplishment of ICSH objectives https://www.cdc.gov/tobacco/about/icsh/index.htm.
The U.S. Department of Health and Human Services policy stipulates
that committee membership be balanced in terms of points of view
represented, and the committee's function. Appointments shall be made
without discrimination on the basis of age, race, ethnicity, gender,
sexual orientation, gender identity, HIV status, disability, and
cultural, religious, or socioeconomic status. Nominees must be U.S.
citizens,
[[Page 53317]]
and cannot be full-time employees of the U.S. Government. Current
participation on federal workgroups or prior experience serving on a
federal advisory committee does not disqualify a candidate; however,
HHS policy is to avoid excessive individual service on advisory
committees and multiple committee memberships. Committee members are
Special Government Employees, requiring the filing of financial
disclosure reports at the beginning and annually during their terms.
CDC reviews potential candidates for ICSH membership each year and
provides a slate of nominees for consideration to the Secretary of HHS
for final selection. HHS notifies selected candidates of their
appointment near the start of the term in July 2022, or as soon as the
HHS selection process is completed. Note that the need for different
expertise varies from year to year and a candidate who is not selected
in one year may be reconsidered in a subsequent year.
Candidates should submit the following items:
[ssquf] Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, email address).
[ssquf] At least one letter of recommendation from person(s) not
employed by the U.S. Department of Health and Human Services.
(Candidates may submit letter(s) from current HHS employees if they
wish, but at least one letter must be submitted by a person not
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
Nominations may be submitted by the candidate him- or herself, or
by the person/organization recommending the candidate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-20920 Filed 9-24-21; 8:45 am]
BILLING CODE 4163-18-P
